Patel AB, Farooq S, Welborn M, Amaria RN, et al. Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefit. Cancer 2021 Nov 1. doi: 10.1002/cncr.34004.
PMID: 34724197